In observation of National Protect Your Hearing Month, the International Hearing Society is urging the public to prioritize routine annual hearing evaluations to combat rising rates of noise-induced hearing loss.
WSA’s Signia and Widex brands have received 2026 Hearing Technology Innovator Awards for advancements in AI-driven sound processing and cloud-based fitting software.
The Department of Education’s exclusion of audiology from its new federal “professional degree” designation could have the unexpected benefit of prompting the profession to explore collaborative solutions and intensify advocating for policy change.
The France-based clinical-stage biotech, known for its pipeline of gene therapies targeting hearing loss, has confidentially submitted a draft registration statement to the SEC as it evaluates a potential listing on a US national exchange.
Research set to be presented in Los Angeles links hearing loss to type 2 diabetes, cognitive decline, and the growing GLP-1 medication landscape—underscoring hearing health's expanding role in whole-body care.
The six-module online resource is designed to help audiologists, CI surgeons, and advocates protect cochlear implant coverage as OBBBA-driven Medicaid changes take effect as early as December 2026.
Auditdata has appointed Christoffer Spangenberg as its new CEO, succeeding Kurt Bager, effective September 25, 2026.
Sensorion has announced registration details for its upcoming SENS-601 Program Day on September 22, 2026, which will spotlight the science, patient population, and clinical trial design for its lead GJB2 gene therapy candidate. The event will feature key insights from company leadership and clinical experts regarding the HearConnex trial aimed at addressing hereditary hearing loss.
Signia recently gathered hearing care professionals in Dallas to mark the U.S. launch of its new Multi-adaptive Xperience (MaX) platform, a multi-dimensional AI hearing aid technology designed to help wearers navigate complex group conversations in noise.